Eledon Pharmaceuticals, Inc. (ELDN)

Typically moves ±4.50% on earnings

EARNINGS ANALYTICS

event_upcoming Est. Next Earnings: 2026-11-13 ESTIMATED

Eledon Pharmaceuticals, Inc. (ELDN) has a 22-report earnings history dating back to May 13, 2021. Its average absolute post-earnings move is ±4.50%, and 59.1% of those reactions were positive. Its largest post-earnings gain was +13.54% (Nov 12, 2021) and its largest decline was -13% (May 11, 2023). The next earnings report is predicted for 2026-11-13 (estimated).

Earnings reactions

How ELDN moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±4.50%

Positive %

59.1%

Negative %

40.9%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 13, 2026	☽ POST	-4.59%	open_in_new
May 13, 2026	☽ POST	+1.8%	open_in_new
Mar 19, 2026	☽ POST	+1.05%	open_in_new
Nov 14, 2025	☽ POST	-7.95%	open_in_new
Aug 14, 2025	☽ POST	+1.15%	open_in_new
May 14, 2025	☽ POST	+2.12%	open_in_new
Mar 20, 2025	☽ POST	+2.03%	open_in_new
Nov 12, 2024	☽ POST	-11.41%	open_in_new
Aug 14, 2024	☽ POST	+1.48%	open_in_new
May 13, 2024	☽ POST	+6.85%	open_in_new
Mar 28, 2024	☽ POST	-3.4%	open_in_new
Nov 09, 2023	☽ POST	+0.87%	open_in_new
Aug 10, 2023	☀ PRE	+1.65%	open_in_new
May 11, 2023	☽ POST	-13%	open_in_new
Mar 30, 2023	☽ POST	-5.98%	open_in_new
Nov 14, 2022	☽ POST	-3.65%	open_in_new
Aug 11, 2022	☽ POST	-1.15%	open_in_new
May 12, 2022	☽ POST	+9.95%	open_in_new
Mar 24, 2022	☽ POST	+4%	open_in_new
Nov 12, 2021	☀ PRE	+13.54%	open_in_new
Aug 12, 2021	☽ POST	-0.79%	open_in_new
May 13, 2021	☽ POST	+0.57%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±4.50%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 19 →

Funds holding

$50254852

Total value held

Buying

18 added · 1 reduced

Blackrock, Inc.

$20187937 +16.92%

Goldman Sachs Group Inc

$9890613 +578.30%

State Street Corp

$6390558 +40.47%

Ubs Group Ag

$4130085 NEW BUY

Bank Of America Corp /De/

$3479402 +1.56%

SEC Filing Types

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
S-8	20260904	open_in_new SEC.gov
10-Q	20260813	open_in_new SEC.gov
8-K	20260813	open_in_new SEC.gov
4	20260804	open_in_new SEC.gov
4	20260804	open_in_new SEC.gov
SCHEDULE 13G	20260731	open_in_new SEC.gov
8-K	20260622	open_in_new SEC.gov
SCHEDULE 13G/A	20260515	open_in_new SEC.gov
10-Q	20260513	open_in_new SEC.gov
8-K	20260513	open_in_new SEC.gov

Frequently asked about ELDN earnings

When does Eledon Pharmaceuticals, Inc. report earnings next? expand_more

Eledon Pharmaceuticals, Inc. (ELDN)'s next earnings date is estimated for 2026-11-13. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does ELDN stock move after earnings? expand_more

Over 22 reports, ELDN has moved an average of ±4.50% the session after earnings, closing higher 59.1% of the time.

What was ELDN's biggest post-earnings move? expand_more

ELDN's largest post-earnings gain on record was +13.54% on Nov 12, 2021, and its largest decline was -13% on May 11, 2023.

Where can I find Eledon Pharmaceuticals, Inc.'s SEC filings? expand_more

All of Eledon Pharmaceuticals, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.